This report covers an in depth market analysis of neuromodulation devices worldwide. A detailed analysis of the market size in terms of the annual revenue in USD million is provided for the period 2012 to 2018. Neuromodulation devices have emerged as one of the fastest-growing segments in the medical devices market. The neuromodulation devices market is expected to show high growth in the next decade due to an increase in minimally invasive treatment options and medical tourism.
This research report provides a detailed analysis of the global neuromodulation devices market and also covers the various driving factors responsible for the growth of this market. The executive summary comprises the market snapshot which gives details about various segments and sub-segments of the neuromodulation devices market. The qualitative details of the market dynamics of the neuromodulation devices market such as drivers, restraints and opportunities, that influence the current nature and future status of this field, are covered under the market overview section of this report. Impact analysis of drivers, restraints and opportunities are also mentioned in the section. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global neuromodulation devices market. All these factors would help the market players to decide upon the business strategies and plans to be implemented in the near future for the global neuromodulation devices market.
The global neuromodulation devices market is classified based on type of technology, application area and geography. The market size and estimates from 2011 to 2018 for each of these segments is provided in USD million in this report. The neuromodulation devices market based on the type of technology is segmented into: spinal cord stimulation medical devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices and gastric electric stimulation devices. Furthermore, on the basis of different application areas, the market is segmented into: Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems, St. Jude Medical’s Eon Mini Neurostimulator System, Boston Scientific’s Precision Spinal Cord Stimulation System, Nevro’s Senza System for Spinal Cord Stimulation, Cyberonics’ VNS Therapy System, Codman & Shurtleff’s Medstream System, Medtronic’s Enterra Therapy System and IntraPace’s abiliti system. A detailed market analysis of the above segments has been provided on a geographical level in this study, based on their market size and forecast in terms of USD million for the period 2010 to 2018. The compound annual growth rate (CAGR) has been estimated for the period 2012 to 2018, considering 2011 as the base year.
In terms of geographical distribution, the global neuromodulation devices market has been categorized into four geographical regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section also includes the market size and forecast of the regional markets mentioned above for the period 2012 to 2018 along with their respective growth rates. The report covers competitive landscape section, which includes market share and competitive strategies of the key market players. This report also includes strategic recommendations, which would be useful for the current and future market players to sustain, grow and establish an enviable position in the global neuromodulation devices market.
This report concludes with the company profiles section, which comprises key information such as company overview, financial overview, product portfolio, SWOT analysis, business strategies, and recent developments about the major players in the neuromodulation devices market. Some of the key players profiled in this report include Medtronic, St. Jude Medical, Boston Scientific Group, Cyberonics, Nevro, Codman and Shurtleff, Integra, IntraPace, Neuronetics Inc., Cervel Neurotech Inc. and Uroplasty.